Although rituximab use was associated with higher odds of severe or, critical COVID-19 disease, it did not reach statistical significance which might be due to small sample size of our study.
← all excerpts
Managing ANCA-associated vasculitis during COVID-19 pandemic: a single-center cross-sectional study.
1
—
—